Clinical Trial Update: Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating chemotherapy in combination with inotuzumab ozogamicin in subjects with B-cell lymphoma (non-Hodgkin's lymphoma) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma B-cell
• Non-hodgkin Lymphoma

Drugs mentioned

• Inotuzumab ozogamicin (inotuzumab ozogamicin)

Snippet

Sponsor: Pfizer | Conditions: Lymphoma, B-Cell | Phase 1 | Status: COMPLETED | Results posted: 2019-08-02